RecruitingNCT06806488

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

Studying Lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Principal Investigator
Pier Luigi Zinzani, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Enrollment
160 target
Eligibility
18 years · All sexes
Timeline
2025 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06806488 on ClinicalTrials.gov

Other trials for Lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Lymphoma →

← Back to all trials